Scholarlink

Trimetazidine was originally developed for management of stable angina pectoris. Small studies suggest it is similarly efficacious to betahistine in the management of Ménière’s disease. Trimetazidine can cause or worsen parkinsonism. It is not currently FDA approved.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Trimetazidine

  • 章节

  • 发表日期：

    2025年

查看全文
  • Marcello Cherchi

摘要

Trimetazidine was originally developed for management of stable angina pectoris. Small studies suggest it is similarly efficacious to betahistine in the management of Ménière’s disease. Trimetazidine can cause or worsen parkinsonism. It is not currently FDA approved.